Literature DB >> 31140320

Change in HbA1c concentration as decision parameter for frequency of HbA1c measurement.

Jens K Munk1, Bent S Lind1, Henrik L Jørgensen1,2.   

Abstract

Hemoglobin A1c (HbA1c) is a long-term measure for glucose concentration in plasma. Since its introduction as a diabetes monitoring tool, and its more recent application as a diagnostic tool, the number of measurements of HbA1c have risen dramatically. However, HbA1c change is slow, so repeating measurements should not be done too often. We use a large, unfiltered dataset from 52,017 patients to determine the possible rate of change in HbA1c concentration. In our laboratory, the critical difference between HbA1c measurements is 8.5%. Our data show that a 1-unit HbA1c rise takes 4 weeks to occur, hence, at a HbA1c concentration around 50 mmol/mol Hgb, a critically increased HbA1c concentration cannot be determined until after 16 weeks. Conversely a critically lower HbA1c can manifest itself after 2 weeks, but after 7 weeks the dropping tendency stops. The amount of measurements that can be cancelled because they were taken sooner than 16 weeks is 23 percent.

Entities:  

Keywords:  Glycated Hemoglobin A; clinical chemistry tests; clinical laboratory information systems; economics; medical

Mesh:

Substances:

Year:  2019        PMID: 31140320     DOI: 10.1080/00365513.2019.1622032

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump.

Authors:  Emmanouil S Benioudakis; Evangelos D Georgiou; Eirini D Barouxi; Athanasios M Armagos; Vaia Koutsoumani; Faidra Anastasiou-Veneti; Eleni Koutsoumani; Maria Brokalaki
Journal:  Diabetol Int       Date:  2020-11-16

2.  Blood tests - too much of a good thing.

Authors:  Henrik L Jørgensen; Bent S Lind
Journal:  Scand J Prim Health Care       Date:  2022-06       Impact factor: 3.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.